Nutex Health, Inc.

NASDAQ:NUTX

Medical - Healthcare Information Services

Healthcare
$172.74 +1.94%

+$2.84 today

Market cap
$1.19B
Beta
2.06
P/E (TTM)
10.4
EPS (TTM)
$14.38
52W Low $77.21High $193.07

Volume 0.16M

Average 0.17M

NUTX Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Nutex Health, Inc.NASDAQ: NUTX

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization growth accelerates

Q1 FY2026 depreciation & amortization of $5.49M rose 7.9% year over year, ahead of the +5.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 5.9% from the prior quarter. Over 3 fiscal years it compounded at +16.1% a year.

Context

  • Depreciation & amortization amounted to 2.3% of revenue in FY2025, down 1.6 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +7.9% holds above the trailing-twelve-month pace of +5.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.49M+5.9% QoQ
Last fiscal yearDec 2025
$20.53M+8.2% YoY
LTMMar 2026
$20.93M+5.3% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.9%——
1 year+8.2%——
3-year CAGR+16.1%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
20.53M USD
Year-over-year change
+8.2%
4-year CAGR
+27.5%

Depreciation & Amortization vs competitors

How NUTX compares with its peers on the latest reported figures

  • NUTX's LTM Mar 2026 depreciation & amortization of $20.93M is the 10th highest of the 11 companies compared; the peer median is $169.89M.
  • Its year-over-year change of +5.3% is the 10th highest of 11, against a peer median of +11.1%.
  • Depreciation & amortization amounts to 2.4% of revenue for NUTX, versus a peer median of 3.4%.
NUTX Competitors Peer median
Depreciation & Amortization for NUTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
THCTenet Healthcare CorporationLTM Jun 2026$893M +9.4%+0.9%4.1%
CYHCommunity Health Systems, Inc.LTM Mar 2026$734M +85.4%-1.7%3.4%
UHSUniversal Health Services, Inc.LTM Jun 2026$641.16M +7.5%+2.1%3.5%
EHCEncompass Health CorporationLTM Jun 2026$346.5M +9.8%+10.4%5.6%
SGRYSurgery Partners, Inc.LTM Sep 2026$177.3M +18.2%+15.3%5.3%
ARDTArdent Health Partners, LLCLTM Mar 2026$162.49M +10.4%+4.1%2.5%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$79.99M +12.4%+1.0%3.4%
ASTHAstrana Health, Inc.LTM Mar 2026$54.38M +83.2%+37.6%1.5%
AGLAgilon Health, Inc.LTM Mar 2026$28.51M +11.8%+27.6%0.5%
NUTXNutex Health, Inc.LTM Mar 2026$20.93M +5.3%+16.1%2.4%
INNVInnovAge Holding Corp.LTM Mar 2026$20.17M -5.9%+11.9%2.1%
Peer median (excluding NUTX) $169.89M+11.1%+7.2%3.4%

Competitors are the stored peer set for NUTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue331.53M219.29M247.65M479.95M875.26M
Cost of Revenue152.25M203.87M212.87M283.69M430.98M
Gross Profit179.28M15.42M34.77M196.26M444.28M
Gross Margin54.1%7.0%14.0%40.9%50.8%
Research & Development285.88K0000
Selling, General & Admin5.46M20M36.07M58.56M168.66M
Operating Expenses9.02M422.02M66.55M65.64M168.66M
Depreciation & Amortization7.76M13.13M17.59M18.97M20.53M
EBITDA183.45M(394.03M)(14.58M)148.65M287.54M
EBITDA Margin55.3%-179.7%-5.9%31.0%32.9%
Operating Income170.26M(406.6M)(31.77M)130.62M275.63M
Operating Margin51.4%-185.4%-12.8%27.2%31.5%
Interest Income00000
Interest Expense6.2M12.49M16.32M19.93M22.23M
Other Income / Expenses(773.88K)(13.05M)(16.72M)(20.87M)(30.84M)
Income Before Tax169.49M(419.65M)(48.49M)109.75M244.78M
Pre-Tax Margin51.1%-191.4%-19.6%22.9%28.0%
Income Tax Expense965.73K13.09M(5.07M)14.48M64.42M
Net Income132.59M(424.78M)(45.79M)52.18M70.79M
Net Margin40.0%-193.7%-18.5%10.9%8.1%
EPS (Basic)33.55(100.50)(10.39)10.2311.13
EPS (Diluted)33.55(100.36)(10.39)9.7110.48
Weighted Avg Shares4.02M4.23M4.41M5.1M6.36M
Weighted Avg Shares (Diluted)3.95M4.23M4.41M5.1M6.76M

Nutex Health, Inc.

NASDAQ:NUTX

Intrinsic Alpha fair value

Locked

Current Price

$172.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.